WT

Willis Towers Watson Public Limited Company

Q2 FY26Insurance

Willis Towers Watson Public Limited Company Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price252
Market cap₹23.8K Cr
P/E15.1
Published29 May 2026

What the Q2 FY26 call signalled

2 of 3 strong

RevenueRank 4
MarginRank 2
CapexYes

Not discussed on this call: fundraise, order book.

The short version

- The company expects mid-single-digit organic growth across the enterprise and segments including Risk & Broking (R&B), Health, Wealth, and Career. - WTW delivered 3% organic growth in Q1 2026 with adjusted operating margin of 22.3%.

From Willis Towers Watson Public Limited Company's Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Rank 4
  • The company expects mid-single-digit organic growth across the enterprise and segments including Risk & Broking (R&B), Health, Wealth, and Career.
  • Q1 saw a softer growth mainly due to tough comparables and timing of new business; growth normalizing in April.
  • Health is expected to accelerate, targeting high single-digit organic growth for the full year.
  • Wealth anticipates high end of low single-digit organic growth, supported by new clients and fund activity.
  • Risk & Broking mid-single-digit growth outlook narrowed due to geopolitical and pricing headwinds but long-term outlook remains unchanged.
  • ICT (Insurance Consulting and Technology) expects low to mid-single-digit growth, driven by strong technology sales.
  • New AI-driven products and workforce transformation services indicate meaningful growth potential in the latter part of the year.
  • Overall, WTW is confident to deliver mid-single-digit organic growth in 2026 across segments.

Profitability & Margins

See what Willis Towers Watson Public Limited Company said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes
  • WTW is reinvesting a portion of efficiency savings into growth, talent, technology, and capabilities to drive long-term value and margin expansion.
  • Continued investments in technology, especially AI and automation, support operating leverage and efficiency across the business.
  • Launch of AI-powered operating system "Neuron" globally to improve service and efficiency.
  • Integration of NewFront's AI broking platform technology into WTW to create an end-to-end digital ecosystem.
  • Strategic hiring continues, including new investment hires with a full year to ramp up.
  • Capital allocation priorities include at least $1 billion in share repurchases, with flexibility to invest in organic growth and disciplined M&A aligned with long-term strategy.
  • Emphasis on scaling AI-driven products and workforce adoption to compound growth and margin gains over time.

Fundraising & Capital Structure

See what Willis Towers Watson Public Limited Company said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company mentions a **healthy pipeline** of new business and deliverable projects across specialties, especially in Europe and Asia.
  • They expect **pipeline conversions** to contribute meaningfully to revenue growth during the remainder of the year.
  • The pipeline includes **technical advisory support** on issues such as EU pay transparency, M&A transactions, total rewards, and AI workforce transformation projects.
  • The Risk & Broking segment has a **strong pipeline** despite some delays due to geopolitical uncertainties like the Middle East conflict.
  • The Insurance Consulting and Technology (ICT) segment has a **technology pipeline conversion** leading to increased growth.
  • Momentum is building following integration efforts such as NewFront, bringing new capabilities and talent to support pipeline conversion.
  • While Q1 showed some timing-related delays, **growth returned to normalized levels in April**, indicating effective orderbook conversion.

How does Willis Towers Watson Public Limited Company rank vs peers in Insurance?

Pro feature
ThisWillis Towers Watson Public Limited Company
Rev 4Mar 2

Others in Insurance this season

  • American Financial Group, Inc. (Q2 FY26)

    American Financial Group, Inc. Q2 FY26 quarterly results analysis. Crop insurance gross written premium expected to be flat; net written premiums projected to i

  • Erie Indemnity Company (Q2 FY26)

    Erie Indemnity Company Q2 FY26 quarterly results analysis. Erie expects continued rollout and expansion of Erie Secure Auto into additional states this year, fo

  • CNA Financial Corporation (Q2 FY26)

    CNA Financial Corporation Q2 FY26 quarterly results analysis. Net written premium growth was 1% in Q1 2026, with significant variation by segment and class. Mar

  • RenaissanceRe Holdings Ltd. (Q2 FY26)

    RenaissanceRe Holdings Ltd. Q2 FY26 quarterly results analysis. New demand at midyear renewals is increasing, now estimated closer to $15 billion for U.S. Marke

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Willis Towers Watson Public Limited Company Q2 FY26 results?

- The company expects mid-single-digit organic growth across the enterprise and segments including Risk & Broking (R&B), Health, Wealth, and Career. - WTW delivered 3% organic growth in Q1 2026 with adjusted operating margin of 22.3%.

What is Willis Towers Watson Public Limited Company share price analysis?

Willis Towers Watson Public Limited Company currently shows a neutral. The stock trades at a P/E of 15.1 with a market cap of $23,802. Investors should review the full earnings analysis for detailed insights.

Is Willis Towers Watson Public Limited Company planning capital expenditure?

- WTW is reinvesting a portion of efficiency savings into growth, talent, technology, and capabilities to drive long-term value and margin expansion.

Keep Willis Towers Watson Public Limited Company on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.